Log In
Print
BCIQ
Print
Print this Print this
 

SAR302503 (formerly TG101348)

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionSelective oral Janus kinase-2 (JAK-2) inhibitor
Molecular Target Janus kinase-2 (JAK-2)
Mechanism of ActionJanus kinase-2 (JAK-2) inhibitor
Latest Stage of DevelopmentPhase III
IndicationMyeloproliferative disorder
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today